Home › Targets › TYK2

TYK2 (2 companies · 6 programs)

Companies with an active program directed at TYK2.

ALUMIS INC. ALMS

  • envudeucitinib — Plaque Psoriasis Phase 3
  • envudeucitinib — Systemic Lupus Erythematosus Phase 2
  • A-005 — Multiple Sclerosis Phase 1
  • envudeucitinib — Sjögren's Disease
  • envudeucitinib — Cutaneous Lupus Erythematosus